IDEAYA Biosciences, Inc.
IDYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $119,244 | -$77,491 | -$72,178 | -$130,312 |
| Dep. & Amort. | $1,030 | $1,233 | $1,133 | $643 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,217 | $11,868 | $10,237 | $9,485 |
| Change in WC | $11,705 | $4,608 | $4,244 | $469 |
| Other Non-Cash | -$1,982 | -$2,692 | -$3,778 | -$1,940 |
| Operating Cash Flow | $142,214 | -$62,474 | -$60,342 | -$121,655 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | -$663 | -$1,330 | -$1,102 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$138,991 | -$127,553 | -$105,207 | -$337,041 |
| Inv. Sales/Matur. | $180,800 | $174,134 | $186,354 | $141,034 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $41,767 | $45,918 | $79,817 | -$197,109 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $301 | $1,205 | $25,009 | -$405 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1,134 | $3,158 |
| Financing Cash Flow | $301 | $1,205 | $26,143 | $2,753 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $184,282 | -$15,351 | $45,618 | -$316,011 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $115,450 | $129,996 | $85,183 | $401,194 |
| End Cash | $299,732 | $114,645 | $130,801 | $85,183 |
| Free Cash Flow | $142,172 | -$63,137 | -$61,672 | -$122,757 |